Goldman Sachs
-
GSK has fulled exited Haleon, enabling it to fully concentrate on its pharmaceuticals and vaccines business
-
◆ Quick fire from the US bulge bracket bank makes this its second deal in May and fourth this year ◆ NatWest returns with senior opco Yankee a week after blowout AT1 ◆ CPI report improves market conditions
-
French president’s call for international consolidation bucks a long trend of political opposition
-
Leads saw no new issue premium paid by the issuer after 3bp of tightening
-
Sovereign to focus on preserving and injecting secondary liquidity next
-
After CVC's successful IPO last week, Spain's Puig has taken this week's spotlight
-
French agency capitalises on rare capital market visit
-
Sovereign issuer passed ‘real test for investors appetite’ after returning to IG ratings status
-
◆ Money centre banks drive $25bn-plus three-day issuance rush ◆ Goldman first refinances capital with new, cheaper deal and then returns for senior funding ◆ RBC debuts its most subordinated debt in US dollars
-
German agency gets €19bn of orders despite slowdown before holiday
-
SSA issuers jump into first available window after several central bank rates decisions
-
The biggest IPO of 2024 so far in Europe has delivered a welcome bounce in the aftermarket